Page last updated: 2024-12-06

dup 105

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-methylsulfinylphenyloxooxazolidinylmethylacetamide: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID57141
CHEMBL ID316369
SCHEMBL ID4399878
MeSH IDM0154438

Synonyms (19)

Synonym
CHEMBL316369
dup 105
n-[[(5s)-3-(4-methylsulfinylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide
dup-105
4-methylsulfinylphenyloxooxazolidinylmethylacetamide
acetamide, n-((3-(4-(methylsulfinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)-, (s)-
96800-41-8
unii-dyqqguhgvt
dyqqguhgvt ,
SCHEMBL4399878
HY-101726
CS-6816
DTXSID80914313
n-({3-[4-(methanesulfinyl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)ethanimidic acid
acetamide, n-(((5s)-3-(4-(methylsulfinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)-
n-(((5s)-3-(4-(methylsulfinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide
dup105
gtpl10950
AKOS040733044

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID698976Antimycobacterial activity against Mycobacterium tuberculosis2012European journal of medicinal chemistry, May, Volume: 51Tuberculosis: the drug development pipeline at a glance.
AID207054In vitro for antibacterial activity against Staphylococcus aureus strain SFCO-1a1990Journal of medicinal chemistry, Sep, Volume: 33, Issue:9
Antibacterials. Synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 2. The "A" group.
AID67419In vitro for antibacterial activity against Enterococcus faecalis strain STCO-191990Journal of medicinal chemistry, Sep, Volume: 33, Issue:9
Antibacterials. Synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 2. The "A" group.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (63.64)18.7374
1990's3 (27.27)18.2507
2000's0 (0.00)29.6817
2010's1 (9.09)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.71

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.71 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.20 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.71)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (9.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]